Camille Roux

ORCID: 0000-0001-9497-1446 · 1 paper in corpus

article 1995

Bone loss during gonadotropin releasing hormone agonist treatment and use of nasal calcitonin

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA ·doi:10.1007/bf02106098

Gonadotropin releasing hormone (GnRH) agonists have shown to be effective in the treatment of several sex-hormone-dependent conditions. However, their use could be limited by the bone loss they induce. To evaluate the use of nasal salmon ca…